Analysis of gene expression in induced pluripotent stem cell-derived human neurons exposed to botulinum neurotoxin a subtype 1 and a type a atoxic derivative

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Scherf, Jacob M ^a   Hu, Xiaoyang Serene ^a   Tepp, William H ^a   Ichtchenko, Konstantin ^b   Johnson, Eric A ^a   Pellett, Sabine ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN; BOTULINUM TOXIN A ATOXIC DERIVATIVE; BOTULINUM TOXIN A1; CALCIUM CHANNEL; SYNAPTOSOMAL ASSOCIATED PROTEIN 25; TRANSCRIPTOME; UNCLASSIFIED DRUG; BOTULINUM TOXIN A;

ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; NERVE CELL; NERVE FIBER GROWTH; PLURIPOTENT STEM CELL; CELL CULTURE; CLUSTER ANALYSIS; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; INDUCED PLURIPOTENT STEM CELL; METABOLISM; REPRODUCIBILITY; TIME FACTOR;

BOTULINUM TOXINS, TYPE A; CELLS, CULTURED; CLUSTER ANALYSIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; INDUCED PLURIPOTENT STEM CELLS; NEURONS; REPRODUCIBILITY OF RESULTS; TIME FACTORS;

EID: 84908391448     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0111238     Document Type: Article

References (70)

1. Johnson EA (2005) Clostridium botulinum and Clostridium tetani. In: S. P. Borriello PRMaGF, editor. Topley and Wilson's microbiology and microbial infections. London, United Kingdom: Hodder Arnold. pp. 1035-1088.
2. Johnson EA, Montecucco C (2008) Chapter 11 Botulism. In: Andrew GE, editor. Handbook of Clinical Neurology: Elsevier. pp. 333-368.
3. Arnon SS, Schechter R, Inglesby TV, Henderson DA, Bartlett JG, et al.. (2001) Botulinum toxin as a biological weapon: medical and public health management. JAMA: the journal of the American Medical Association 285:1059-1070.
4. Gimenez DF, Gimenez JA (1995) The typing of botulinal neurotoxins. International journal of food microbiology 27:1-9.
5. Smith TJ, Lou J, Geren IN, Forsyth CM, Tsai R, et al.. (2005) Sequence variation within botulinum neurotoxin serotypes impacts antibody binding and neutralization. Infection and immunity 73:5450-5457.
6. Brashear A (2010) Botulinum toxin type A: Exploring new indications. Drugs of today (Barcelona, Spain: 1998) 46:671-682.
7. Dressler D (2012) Clinical applications of botulinum toxin. Curr Opin Microbiol. England. pp. 325-336.
8. Chaddock JA, Marks PM (2006) Clostridial neurotoxins: structure-function led design of new therapeutics. Cellular and molecular life sciences: CMLS 63:540-551.
9. Rummel A (2013) Double receptor anchorage of botulinum neurotoxins accounts for their exquisite neurospecificity. Curr Top Microbiol Immunol 364:61-90.
10. Fischer A, Montal M (2007) Crucial role of the disulfide bridge between botulinum neurotoxin light and heavy chains in protease translocation across membranes. The Journal of biological chemistry 282:29604-29611.
11. Fischer A, Montal M (2007) Single molecule detection of intermediates during botulinum neurotoxin translocation across membranes. Proceedings of the National Academy of Sciences of the United States of America 104:10447-10452.
12. Pantano S, Montecucco C (2014) The blockade of the neurotransmitter release apparatus by botulinum neurotoxins. Cell Mol Life Sci 71:793-811.
13. Blasi J, Chapman ER, Link E, Binz T, Yamasaki S, et al.. (1993) Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25. Nature 365:160-163.
14. Whitemarsh RC, Tepp WH, Johnson EA, Pellett S (2014) Persistence of botulinum neurotoxin a subtypes 1-5 in primary rat spinal cord cells. PLoS One 9:e90252.
15. Foran PG, Mohammed N, Lisk GO, Nagwaney S, Lawrence GW, et al.. (2003) Evaluation of the therapeutic usefulness of botulinum neurotoxin B, C1, E, and F compared with the long lasting type A. Basis for distinct durations of inhibition of exocytosis in central neurons. The Journal of biological chemistry 278:1363-1371.
16. Keller JE, Cai F, Neale EA (2004) Uptake of botulinum neurotoxin into cultured neurons. Biochemistry 43:526-532.
17. Bade S, Rummel A, Reisinger C, Karnath T, Ahnert-Hilger G, et al.. (2004) Botulinum neurotoxin type D enables cytosolic delivery of enzymatically active cargo proteins to neurones via unfolded translocation intermediates. J Neurochem 91:1461-1472.
18. Band PA, Blais S, Neubert TA, Cardozo TJ, Ichtchenko K (2010) Recombinant derivatives of botulinum neurotoxin A engineered for trafficking studies and neuronal delivery. Protein Expr Purif 71:62-73.
19. Pellett S, Tepp WH, Stanker LH, Band PA, Johnson EA, et al.. (2011) Neuronal targeting, internalization, and biological activity of a recombinant atoxic derivative of botulinum neurotoxin A. Biochemical and biophysical research communications 405:673-677.
20. Coffield JA, Yan X (2009) Neuritogenic actions of botulinum neurotoxin A on cultured motor neurons. The Journal of pharmacology and experimental therapeutics 330:352-358.
21. Angaut-Petit D, Molgó J, Comella JX, Faille L, Tabti N (1990) Terminal sprouting in mouse neuromuscular junctions poisoned with botulinum type A toxin: morphological and electrophysiological features. Neuroscience 37:799-808.
22. Bonner PH, Friedli AF, Baker RS (1994) Botulinum A toxin stimulates neurite branching in nerve-muscle cocultures. Brain researchDevelopmental brain research 79:39-46.
23. Juzans P, Comella JX, Molgo J, Faille L, Angaut-Petit D (1996) Nerve terminal sprouting in botulinum type-A treated mouse levator auris longus muscle. Neuromuscul Disord 6:177-185.
24. Diaz J, Molgó J, Pécot-Dechavassine M (1989) Sprouting of frog motor nerve terminals after long-term paralysis by botulinum type A toxin. Neurosci Lett 96:127-132.
25. Holland RL, Brown MC (1981) Nerve growth in botulinum toxin poisoned muscles. Neuroscience 6:1167-1179.
26. Thirunavukkarasusx N, Ghosal KJ, Kukreja R, Zhou Y, Dombkowski A, et al.. (2011) Microarray analysis of differentially regulated genes in human neuronal and epithelial cell lines upon exposure to type A botulinum neurotoxin. Biochem Biophys Res Commun 405:684-690.
27. Mukund K, Mathewson M, Minamoto V, Ward SR, Subramaniam S, et al.. (2014) Systems Analysis of Transcriptional Data Provides Insights Into Muscle's Biological Response to Botulinum Toxin. Muscle Nerve.
28. Xiaoxue W, Xi C, Zhibo X (2014) Effects of botulinum toxin type A on expression of genes in keloid fibroblasts. Aesthet Surg J 34:154-159.
29. Malizio CJ, Goodnough MC, Johnson EA (2000) Purification of Clostridium botulinum type A neurotoxin. Methods in molecular biology (Clifton, NJ) 145:27-39.
30. Schantz EJ, Kautter DA (1978) Standardized assay for Clostridium botulinum toxins. Journal - Association of Official Analytical Chemists 61:96-99.
31. Hatheway CL (1988) Botulism. In: Balows A, Hausler WH, Ohashi M, Turano MA, editors. Laboratory diagnosis of infectious diseases: principles and practice. New York: Springer-Verlag. pp. 111-133.
32. Pellett S, Tepp WH, Toth SI, Johnson EA (2010) Comparison of the primary rat spinal cord cell (RSC) assay and the mouse bioassay for botulinum neurotoxin type A potency determination. Journal of pharmacological and toxicological methods 61:304-310.
33. Pellett S, Tepp WH, Clancy CM, Borodic GE, Johnson EA (2007) A neuronal cell-based botulinum neurotoxin assay for highly sensitive and specific detection of neutralizing serum antibodies. FEBS letters 581:4803-4808.
34. Huang DW, Sherman BT, Lempicki RA (2009) Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 37:1-13.
35. Huang DW, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4:44-57.
36. Edgar R, Domrachev M, Lash AE (2002) Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 30:207-210.
37. Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, et al.. (2013) NCBI GEO: archive for functional genomics data sets-update. Nucleic Acids Res 41:D991-995.
38. Ye J, Coulouris G, Zaretskaya I, Cutcutache I, Rozen S, et al.. (2012) Primer-BLAST: a tool to design target-specific primers for polymerase chain reaction. BMC Bioinformatics 13:134.
39. Whitemarsh RC, Strathman MJ, Chase LG, Stankewicz C, Tepp WH, et al.. (2012) Novel application of human neurons derived from induced pluripotent stem cells for highly sensitive botulinum neurotoxin detection. Toxicological sciences: an official journal of the Society of Toxicology 126:426-435.
40. Rossert J, Terraz C, Dupont S (2000) Regulation of type I collagen genes expression. Nephrol Dial Transplant 15 Suppl 6:66-68.
41. Muragaki Y, Mattei MG, Yamaguchi N, Olsen BR, Ninomiya y (1991) The complete primary structure of the human alpha 1 (VIII) chain and assignment of its gene (COL8A1) to chromosome 3. Eur J Biochem 197:615-622.
42. Bernard M, Yoshioka H, Rodriguez E, Van Der Rest M, Kimura T, et al.. (1988) Cloning and sequencing of pro-alpha 1 (XI) collagen cDNA demonstrates that type XI belongs to the fibrillar class of collagens and reveals that the expression of the gene is not restricted to cartilagenous tissue. J Biol Chem 263:17159-17166.
43. Hashimoto T, Maekawa S, Miyata S (2009) IgLON cell adhesion molecules regulate synaptogenesis in hippocampal neurons. Cell Biochem Funct 27:496-498.
44. Noonan EJ, Place RF, Giardina C, Hightower le (2007) Hsp70B' regulation and function. Cell Stress Chaperones 12:393-402.
45. American Society for Aesthetic Plastic Surgery 2012 National Data Bank Statistics. Available: www.surgery.org.
46. Tafoya LC, Shuttleworth CW, Yanagawa Y, Obata K, Wilson MC (2008) The role of the t-SNARE SNAP-25 in action potential-dependent calcium signaling and expression in GABAergic and glutamatergic neurons. BMC Neurosci 9:105.
47. Pozzi D, Condliffe S, Bozzi Y, Chikhladze M, Grumelli C, et al.. (2008) Activitydependent phosphorylation of Ser187 is required for SNAP-25-negative modulation of neuronal voltage-gated calcium channels. Proc Natl Acad Sci U S A 105:323-328.
48. Fujikawa R, Ishii T, Komori S, Nishimura M (2008) Improved calcium utilization at motor nerve terminals exposed to botulinum neurotoxin in mice. J Physiol Sci 58:419-424.
49. Molgo J, Comella JX, Angaut-Petit D, Pecot-Dechavassine M, Tabti N, et al.. (1990) Presynaptic actions of botulinal neurotoxins at vertebrate neuromuscular junctions. J Physiol (Paris) 84:152-166.
50. Hanisch UK, Kettenmann H (2007) Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci 10:1387-1394.
51. Kettenmann H, Hanisch UK, Noda M, Verkhratsky A (2011) Physiology of microglia. Physiol Rev 91:461-553.
52. Araque A, Parpura V, Sanzgiri RP, Haydon PG (1999) Tripartite synapses: glia, the unacknowledged partner. Trends Neurosci 22:208-215.
53. Carmignoto G (2000) Reciprocal communication systems between astrocytes and neurones. Prog Neurobiol 62:561-581.
54. Nedergaard M (1994) Direct signaling from astrocytes to neurons in cultures of mammalian brain cells. Science 263:1768-1771.
55. Finkbeiner S (1992) Calcium waves in astrocytes-filling in the gaps. Neuron 8:1101-1108.
56. Noureddini M, Verdi J, Mortazavi-Tabatabaei SA, Sharif S, Azimi A, et al.. (2012) Human endometrial stem cell neurogenesis in response to NGF and bFGF. Cell Biol Int 36:961-966.
57. Terwisscha Van Scheltinga AF, Bakker SC, Kahn RS, Kas MJ (2013) Fibroblast growth factors in neurodevelopment and psychopathology. Neuroscientist 19:479-494.
58. Siegenthaler JA, Ashique AM, Zarbalis K, Patterson KP, Hecht JH, et al.. (2009) Retinoic acid from the meninges regulates cortical neuron generation. Cell 139:597-609.
59. Lee SA, Belyaeva OV, Wu L, Kedishvili NY (2011) Retinol dehydrogenase 10 but not retinol/sterol dehydrogenase (s) regulates the expression of retinoic acidresponsive genes in human transgenic skin raft culture. J Biol Chem 286:13550-13560.
60. Bolz H, Ramírez A, Von Brederlow B, Kubisch C (2001) Characterization of ADAMTS14, a novel member of the ADAMTS metalloproteinase family. Biochim Biophys Acta 1522:221-225.
61. Kähler AK, Djurovic S, Kulle B, Jönsson EG, Agartz I, et al.. (2008) Association analysis of schizophrenia on 18 genes involved in neuronal migration: MDGA1 as a new susceptibility gene. Am J Med Genet B Neuropsychiatr Genet 147 B: 1089-1100.
62. Harrison SJ, Parrish M, Monaghan AP (2008) Sall3 is required for the terminal maturation of olfactory glomerular interneurons. J Comp Neurol 507:1780-1794.
63. Cheng YC, Chen TA, Chen CY, Liang CM, Liang SM (2012) 3'poly-G-tailed ODNs inhibit F-spondin to induce cell death and neurite retraction in rat embryonic neurons. Mol Neurobiol 45:536-549.
64. Peterziel H, Sackmann T, Strelau J, Kuhn PH, Lichtenthaler SF, et al.. (2011) F-spondin regulates neuronal survival through activation of disabled-1 in the chicken ciliary ganglion. Mol Cell Neurosci 46:483-497.
65. Takita J, Chen Y, Okubo J, Sanada M, Adachi M, et al.. (2011) Aberrations of NEGR1 on 1p31 and MYEOV on 11q13 in neuroblastoma. Cancer Sci 102:1645-1650.
66. Neely GG, Hess A, Costigan M, Keene AC, Goulas S, et al.. (2010) A genomewide Drosophila screen for heat nociception identifies a2d3 as an evolutionarily conserved pain gene. Cell 143:628-638.
67. Pirone A, Kurt S, Zuccotti A, Rüttiger L, Pilz P, et al.. (2014) a2d3 is essential for normal structure and function of auditory nerve synapses and is a novel candidate for auditory processing disorders. J Neurosci 34:434-445.
68. Huh JW, Kim YH, Lee SR, Kim H, Kim DS, et al.. (2009) Gain of new exons and promoters by lineage-specific transposable elements-integration and conservation event on CHRM3 gene. Mol Cells 28:111-117.
69. Lin HJ, Wan L, Chen WC, Lin JM, Lin CJ, et al.. (2012) Muscarinic acetylcholine receptor 3 is dominant in myopia progression. Invest Ophthalmol Vis Sci 53:6519-6525.
70. Krug A, Krach S, Jansen A, Nieratschker V, Witt SH, et al.. (2013) The effect of neurogranin on neural correlates of episodic memory encoding and retrieval. Schizophr Bull 39:141-150.